Back to top of page

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)

- Proposed biomarker or biomarker signature for pain

- Plan for clinical research focused on pain biomarkers

- Identification of pain conditions to be targeted

- Cross functional expertise of the multiple principal investigator (MPI)-led teams

- Centralized resource groups for coordinating clinical trials and standardizing data collection methods, technology development, statistical analysis, and algorithm development

- Measures or biomarker modalities to be used in the biosignature

- Strategy for predicting and/or monitoring therapeutic response for pain

- Timeline for the project

- Budget for the research and development of biomarkers or biomarker signatures

- Potential impact of the proposed biomarkers or biomarker signatures on clinical trials for pain therapeutics

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows